Rx-360 broadens its supply chain security focus

Industry organisation Rx-360 is to set up a dedicated supply chain security workgroup "to develop and share best practices and information on key supply chain security processes and enhance collaboration among supply chain stakeholders." 

The group defines supply chain security as the prevention, detection, and response to economic adulteration, theft, illegal diversion, fraud, and counterfeiting of components and/or finished goods. 

The workgroup will look at the supply chain holistically starting with raw materials and ending when patients receive their medicine, with an initial emphasis on outsourcing, conveyance security and logistics, site and warehouse security, trading partner practices and market surveillance.

"This workgroup will really compliment work already started by Rx-360 but focus on other parts of the supply chain," commented Brian Johnson, senior director for supply chain security at Pfizer.

Rx-360 is perhaps best known for its work on audit sharing, designed to remove redundancy and improve efficiencies in the appraisal of suppliers of ingredients and other raw materials to the pharmaceutical industry (see Rx-360 officially launches shared audit programme).

More details here.